5/11/2026

speaker
Conference Operator

Ladies and gentlemen, greetings and welcome to the Quantum Computing Inc. First Quarter 2026 Shareholder Update Call. At this time, all participants are in a listen-only mode. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Following management's remarks, the call line will open for questions. It is now my pleasure to introduce your host, John Nesbitt, with IMS Investor Relations.

speaker
John Nesbitt
Investor Relations, IMS Investor Relations

Thank you, and I want to welcome everyone to the Quantum Computing Inc. First Quarter 2026 Shareholder Update Call. Before we begin, please note that today's remarks may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding expected results, operational plans, strategy, and market opportunities. These statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act and Section 21E of the Exchange Act and are based on current assumptions and expectations. Forward-looking statements are neither promises nor guarantees and involve risks and certainties that could cause actual results to differ materially. Important factors are discussed in our end report on Form 10-K for the year ended December 31, 2025, and in subsequent SEC filings, including the quarterly report on Form 10-Q for the quarter ended March 31, 2026. We undertake no obligation to update these statements, except as required by law. On the call today, we have Dr. Yu-Ping Wang, Chief Executive Officer and Chairman, and Chris Roberts, Chief Financial Officer. The team will provide an update on the business, followed by a question and answer session. With that, I would now like to turn the call over to management. Please go ahead, Yu-Ping.

speaker
Dr. Yu-Ping Wang
Chief Executive Officer and Chairman

Good afternoon, and thank you for joining us for Quantum Computing Inc.' 's first quarter 2026 earnings call. We made meaningful progress in the first quarter of 2026, executing on our strategic initiatives and furthering our mission of delivery accessible scalable, and cost-effective quantum machines and photonic solutions for practical use across high-growth markets that include high-performance computing, artificial intelligence, cybersecurity, aerospace and defense, and advanced sensing and imaging. We completed two key transactions during the quarter, closing the acquisitions of the Luminar Semiconductor Inc. and the UCRIP LLC. Luminar Semiconductor, which I will refer to as LSI going forward, represents a significant milestone in QSI's strategy to build a vertically integrated, product-driven photonics and quantum technology platform. LSI brings established capabilities in lasers, detectors, advanced packaging and testing, has a strong photonics customer base, and has a broad R&D and manufacturing capabilities that we believe strength our ability to move from small batch to higher volume production. Included in LSI's portfolio are three key subsidiaries. The first is Freedom Photonics. 3D Photonics is a leading-edge R&D and manufacturing facility that provides unique photonic components, modules, and systems, and is recognized for world-class semiconductor laser technology with approximately 25 issued and pending patents. The second is EM4. EM4 is a class 10,035 humidity-controlled cleaning facility and a leading provider of subsystem design and manufacturing, offering comprehensive photonic and fiber-optical module solutions. The EM4 facility is a major supplier to several U.S. government programs and European defense and space markets. And finally, OptoGration has a chip manufacturing facility and a device assembly and testing facility specialized in design, assembly, testing, and low-volume component production. We are currently integrating LSI, and we're excited to onboard their experienced team of operators engineers, and scientists to expand our depth of talent and execution capacity. We're focused on serving and expanding LSI's existing client base and utilizing their technology and their products to drive quantum commercialization in our target markets. The second acquisition completed in the quarter is Nucrib. Nucleus' primary patent portfolio spans quantum optics, RF photonics, and photonic signal processing, which can generate, measure, and distribute intelligent photons over fiber optic cables. Organizations such as NASA, the U.S. Army Research Lab, and major global research universities and customers have used Nucleus technology new curves through the quantum communications systems and the product will enable us to further advance our technology roadmap while fostering our product and solutions portfolio with the goal of further improving the performance robustness and scalability of our technology We announced a key partnership with Quantum Corridor, which plays a Q-side Direct3 quantum optimization machine on Quantum Corridor's network, an interstate quantum-safe commercial communication network in North America. The optimization machine is intended to provide enhanced, secure, and on-demand Direct3 access for institutions and commercial customers on Quantum Corridors network. We believe this is the first data center installation of a directory machine and the first installation of its kind in a commercial data center environment. This collaboration marked a significant step forward in our commercial deployment strategy expanding practical access to a quantum infrastructure for both academic and enterprise users, and reflecting our commercial strategy to make high-performance quantum solutions readily available in IT ecosystems. On the Foundry front, our Tifflin chip R&D and manufacturing facility in Tempe, Arizona, also known as our Step 1, has been ramping up small batch manufacturing. The foundation's capabilities include nanofabrication and inspection, multi-physics simulation, in-house design, and dicing, and prototyping packaging. While the facility has begun generating early revenue, it's important to know that its primary use is as a research and development facility. We are actively in the planning phase and assessing options for a FAB2 facility, a second, much larger foundry which can support higher volume production to extend our long-term manufacturing capacity and enable widespread deployment of quantum-powered hardware. It is our intent that FAB2 facility will be where quantum manufacturing becomes scalable. We look forward to keeping you apprised concerning our Fab2 strategy and the timelines as it progresses. We have made progress on our technology roadmap as we walk toward our commercial strategy of bringing quantum products to a broad market. By evolving from a technology innovator into a full-scale manufacturer capable of delivering quantum-enabled systems at industry scale. It is becoming increasingly clear that we are well-positioned in the marketplace. We believe we have strong quantum optics and integrated photonics foundation that enables affordable and deployable quantum hardware. By focusing on quantum photonics, our technology has the ability to operate at room temperature, dramatically reducing system footprint, complexity, cost, and power requirements. We are following a strategy focused on manufacturing built for scale as we further refine our Fab1 facility and advance planning on Fab2. And finally, We believe we are getting traction across strategic partnerships and government collaboration. Our guiding principles of practicality first, scalability by design, accessibility for all, and innovation with a purpose remain at the core of everything we do as we build the future of quantum for everyone. I will now turn the call over to Chris Roberts, our Chief Financial Officer, to discuss our first quarter 2026 financials.

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-